日本語English简体中文 繁體中文

4565 Nxera Pharma Co.,Ltd.ネクセラファーマTSE Prime / Pharmaceuticals

0 posts

Nxera Pharma Co.,Ltd. (4565) at a glance

Code
4565
Company
Nxera Pharma Co.,Ltd.
Local name
ネクセラファーマ
Market
TSE Prime
Sector
Pharmaceuticals
Share price
¥1,600 -64.0 (-3.85%) Nov 20 close

Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.

Nxera Pharma Co.,Ltd. (4565) Stock Price History

Nxera Pharma Co.,Ltd. closed at ¥1,600 on Nov 20, 2026, +33.8% over 1 month, +86.9% over 1 year.

2026-10-20 今後の執行役向けRSU付与の見直しならびに執行役向け業績連動型ストックオプションプ…2026-10-30 2026年12月期第3四半期決算短信〔IFRS〕(連結)2026-11-04 2026年12月期業績予想の修正に関するお知らせ¥1,813¥1,196Oct 20Nov 20
Price5-day MA25-day MANikkei 225Disclosures
1-Month High¥1,813Nov 13
1-Month Low¥1,196Oct 20
1-Week Change−11.7%vs Nov 13
1-Month Change+33.8%vs Oct 20

If you had invested ¥100,000 1 month ago, it would be worth ¥133,779 today (+33.8%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −11.9%, while this stock moved +33.8%.

Last 10 Trading Days

DateCloseChange% Change
Nov 20 (Fri)¥1,600−64−3.85%
Nov 19 (Thu)¥1,664−44−2.58%
Nov 18 (Wed)¥1,708−37−2.12%
Nov 17 (Tue)¥1,745−62−3.43%
Nov 16 (Mon)¥1,807−6−0.33%
Nov 13 (Fri)¥1,813+25+1.40%
Nov 12 (Thu)¥1,788−23−1.27%
Nov 11 (Wed)¥1,811+15+0.84%
Nov 10 (Tue)¥1,796+92+5.40%
Nov 9 (Mon)¥1,704+117+7.37%
2026-10-20 今後の執行役向けRSU付与の見直しならびに執行役向け業績連動型ストックオプションプ…2026-10-30 2026年12月期第3四半期決算短信〔IFRS〕(連結)2026-11-04 2026年12月期業績予想の修正に関するお知らせ¥1,813¥1,098Aug 20Nov 20
Price5-day MA25-day MANikkei 225Disclosures
3-Month High¥1,813Nov 13
3-Month Low¥1,098Aug 24
1-Month Change+33.8%vs Oct 20
3-Month Change+41.2%vs Aug 20

If you had invested ¥100,000 3 months ago, it would be worth ¥141,218 today (+41.2%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −14.8%, while this stock moved +41.2%.

Last 10 Trading Days

DateCloseChange% Change
Nov 20 (Fri)¥1,600−64−3.85%
Nov 19 (Thu)¥1,664−44−2.58%
Nov 18 (Wed)¥1,708−37−2.12%
Nov 17 (Tue)¥1,745−62−3.43%
Nov 16 (Mon)¥1,807−6−0.33%
Nov 13 (Fri)¥1,813+25+1.40%
Nov 12 (Thu)¥1,788−23−1.27%
Nov 11 (Wed)¥1,811+15+0.84%
Nov 10 (Tue)¥1,796+92+5.40%
Nov 9 (Mon)¥1,704+117+7.37%
2026-10-20 今後の執行役向けRSU付与の見直しならびに執行役向け業績連動型ストックオプションプ…2026-10-30 2026年12月期第3四半期決算短信〔IFRS〕(連結)2026-11-04 2026年12月期業績予想の修正に関するお知らせ¥1,813¥853May 20Nov 20
Price25-day MA75-day MANikkei 225Disclosures
6-Month High¥1,813Nov 13
6-Month Low¥853Aug 3
3-Month Change+41.2%vs Aug 20
6-Month Change+44.4%vs May 20

If you had invested ¥100,000 6 months ago, it would be worth ¥144,404 today (+44.4%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −5.6%, while this stock moved +44.4%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026¥1,600+11.1%
Oct 2026¥1,440+15.3%
Sep 2026¥1,249+9.9%
Aug 2026¥1,136+29.7%
Jul 2026¥876−11.5%
Jun 2026¥990−7.2%
May 2026¥1,067+9.9%
2026-10-20 今後の執行役向けRSU付与の見直しならびに執行役向け業績連動型ストックオプションプ…2026-10-30 2026年12月期第3四半期決算短信〔IFRS〕(連結)2026-11-04 2026年12月期業績予想の修正に関するお知らせ¥1,813¥754Nov 20Nov 20
Price25-day MA75-day MANikkei 225Disclosures
52-Week High¥1,813Nov 13
52-Week Low¥754Dec 19
Year to Date+93.5%vs Dec 30
From 52-Week High−11.7%Nov 13

If you had invested ¥100,000 1 year ago, it would be worth ¥186,916 today (+86.9%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +13.3%, while this stock moved +86.9%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026¥1,600+11.1%
Oct 2026¥1,440+15.3%
Sep 2026¥1,249+9.9%
Aug 2026¥1,136+29.7%
Jul 2026¥876−11.5%
Jun 2026¥990−7.2%
May 2026¥1,067+9.9%
Apr 2026¥971+11.4%
Mar 2026¥872−9.7%
Feb 2026¥966+19.0%
Jan 2026¥812−1.8%
Dec 2025¥827−6.8%
Nov 2025¥887―
¥1,813¥725Nov 20, 2023Nov 20, 2026
Price13-week MA26-week MANikkei 225
3-Year High¥1,813Nov 13, 2026
3-Year Low¥725Apr 7, 2025
Annualized Return+3.3%
Max Drawdown−59.5%

If you had invested ¥100,000 3 years ago, it would be worth ¥110,193 today (+10.2%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +67.8%, while this stock moved +10.2%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥1,600+93.5%
2025¥827―
¥3,115¥725Nov 22, 2021Nov 20, 2026
Price13-week MA26-week MANikkei 225
5-Year High¥3,115May 22, 2023
5-Year Low¥725Apr 7, 2025
Annualized Return−6.4%
Max Drawdown−76.7%

If you had invested ¥100,000 5 years ago, it would be worth ¥71,685 today (−28.3%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +96.3%, while this stock moved −28.3%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥1,600+93.5%
2025¥827―
¥5,618¥28.8Aug 1, 2004Nov 20, 2026
Price1-year MA2-year MANikkei 225
All-Time High¥5,618Apr 2016
All-Time Low¥28.8Sep 2008
Total Change+11.1%vs Aug 2004
Annualized Return+0.5%

If you had invested ¥100,000 in Aug 2004, it would be worth ¥111,111 today (+11.1%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +421.4%, while this stock moved +11.1%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥1,600+93.5%
2025¥827−21.1%
2024¥1,048−26.2%
2023¥1,421−33.5%
2022¥2,138+12.3%
2021¥1,904+5.8%
2020¥1,800−17.1%
2019¥2,171+171.7%
2018¥799−70.8%
2017¥2,735−18.7%
2016¥3,363+35.2%
2015¥2,488+127.7%
2014¥1,093+1.3%
2013¥1,079+106.8%
2012¥522+64.2%
2011¥318−5.9%
2010¥338+29.1%
2009¥262+240.2%
2008¥76.9−80.2%
2007¥388−32.6%
2006¥575−47.0%
2005¥1,085−24.5%
2004¥1,438―

Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Aug 2004). Please check the latest prices before trading.

Nxera Pharma Co.,Ltd. (4565) financial indicators

PBR
2.28
Dividend yield
0.00%

See all financial indicators for Nxera Pharma Co.,Ltd. (market cap, DOE, equity ratio, EV, EBITDA, ROIC and more)

PER, ROE and dividend yield are based on company forecasts, calculated from earnings reports and the closing price after each trading day.

Key features of Nxera Pharma Co.,Ltd. (4565)

Business overview

As a technology-based biopharmaceutical company, it aims to meet unmet needs in Japan and around the world and deliver new specialty medicines that improve patients' quality of life. Its core business spans drug research (discovery) to development and sales, and it has a single pharmaceutical segment. Drug discovery, translational medicine and preclinical and early clinical development are handled mainly by UK-based subsidiary Nxera Pharma UK Limited, and clinical development and sales in Japan and South Korea mainly by 「ネクセラファーマジャパン」 in Japan and Nxera Pharma Korea Co., Ltd. in South Korea, with future expansion into the rest of Asia-Pacific excluding China in view. The UK subsidiary conducts GPCR structural analysis and searches for candidates using its proprietary NxStaR technology.

Summarized from the annual securities report (fiscal year ended December 2025) filed on EDINET.

Position within Pharmaceuticals (79 companies)

PBR2.28xAbove the sector median of 1.86x (No. 47 from the lowest)
Market cap¥146.2 bnNo. 19 in the sector (largest first)

Ranks among stocks in the same Tokyo Stock Exchange sector (33 sectors). PER and PBR of zero or below (losses, negative equity) are excluded and ranked from the lowest.

Price milestones

52-week high¥1,81311/13
52-week low¥7542025/12/19
Current position79.9%Where the low is 0% and the high is 100% (close on 11/20: ¥1,600)
Year to date+93.5%No. 2 of 77 in the sector (best first)
1 year+86.9%

Based on closing prices (adjusted for stock splits, excluding dividends).

Kabutaro's ranking history

Top 50 gainers3 timesLatest: 11/5 (No. 9)

Gainers and losers have been recorded since 9/2026.

Calculated as of 2026/11/20 17:30 JST. Updated every business day in the evening.

Recent disclosures (TDnet, in Japanese)

Filings from the past 12 months (8).

Posts

This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.

No posts yet. Be the first to write something.

Write on the Nxera Pharma Co.,Ltd. board

You will need this to delete your post. Please keep it safe.
By posting you agree to the board rules (Japanese). You are responsible for what you write.

More Japanese stocks in English

Japanese Stock Message Board: stocks available in English

Other boards in English